ReviewFrontiers in antibiotics2025
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials.
Andrew R DiNardo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it